Angiotensin II type I receptor antagonism prevents nicotine-induced cardiac dysfunction in rats

被引：0
|
作者：
Ramalingam, Anand [1 ]
Fauzi, Norsyahida Mohd. [1 ]
Budin, Siti Balkis [1 ]
Ritchie, Rebecca [2 ]
Zainalabidin, Satirah [1 ]
机构：
[1] Univ Kebangsaan Malaysia, Kuala Lumpur, Malaysia
[2] Baker Heart & Diabet Inst, Melbourne, Vic, Australia
来源：
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY | 2020年 / 140卷
关键词：
D O I：
10.1016/j.yjmcc.2019.11.015
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Tue-061
引用
收藏
页码：8 / 8
页数：1
相关论文
共 50 条
  • [41] 5-HT1A receptor antagonism reverses and prevents fluoxetine-induced sexual dysfunction in rats
    Rizzo, Stacey J. Sukoff
    Pulicicchio, Claudine
    Malberg, Jessica E.
    Andree, Terrance H.
    Stack, Gary P.
    Hughes, Zoe A.
    Schechter, Lee E.
    Rosenzweig-Lipson, Sharon
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2009, 12 (08): : 1045 - 1053
  • [42] BMP type I receptor ALK2 is required for angiotensin II-induced cardiac hypertrophy
    Shahid, Mohd
    Spagnolli, Ester
    Ernande, Laura
    Thoonen, Robrecht
    Kolodziej, Starsha A.
    Leyton, Patricio A.
    Cheng, Juan
    Tainsh, Robert E. T.
    Mayeur, Claire
    Rhee, David K.
    Wu, Mei. X.
    Scherrer-Crosbie, Marielle
    Buys, Emmanuel S.
    Zapol, Warren M.
    Bloch, Kenneth D.
    Bloch, Donald B.
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2016, 310 (08): : H984 - H994
  • [43] Pretreatment with Novel Angiotensin type I Receptor Antagonist, Fimasartan, Prevents Doxorubicin-Induced Cardiac Toxicity and Improves Survival
    Chang, Sung-A
    Lim, Byung Kwan
    Lee, Yoo-Jung
    Hong, Mi-Kyung
    Ju, Eun Sun
    Choi, Jin-Oh
    Jeon, Eun-Seok
    CIRCULATION, 2012, 126 (21)
  • [44] PREVENTION OF CHEMOTHERAPY INDUCED CARDIAC DYSFUNCTION BY RENIN-ANGIOTENSIN SYSTEM ANTAGONISM
    Bhullar, N.
    Kotrec, M.
    Zeglinski, M.
    Gollan, M.
    Lytwyn, M.
    Bohonls, S.
    Fang, T.
    Oomah, S.
    Nepomuceno, R.
    Du, X.
    Karlstedt, E.
    Sharma, A.
    Garber, P.
    Singal, P. K.
    Jassal, D. S.
    CANADIAN JOURNAL OF CARDIOLOGY, 2011, 27 (05) : S125 - S125
  • [45] BLADDER DYSFUNCTION AND INCREASED BLADDER EXPRESSION RATIO OF ANGIOTENSIN II TYPE I RECEPTORS AGAINST ANGIOTENSIN II TYPE II RECEPTORS IN AGED RATS
    Mori, K.
    Tobu, S.
    Noguchi, M.
    Sumino, Y.
    Sato, F.
    Mimata, H.
    Yoshimura, N.
    NEUROUROLOGY AND URODYNAMICS, 2013, 32 (06) : 837 - 838
  • [46] Molecular mechanism of angiotensin II type I and type II receptors in cardiac hypertrophy of spontaneously hypertensive rats
    Makino, N
    Sugano, M
    Otsuka, S
    Hata, T
    HYPERTENSION, 1997, 30 (04) : 796 - 802
  • [47] Comparative Efficacy of Angiotensin II Type 1 Receptor Blockers Against Ventilator-Induced Diaphragm Dysfunction in Rats
    Hall, Stephanie E.
    Ahn, Bumsoo
    Smuder, Ashley J.
    Morton, Aaron B.
    Hinkley, J. Matthew
    Wiggs, Michael P.
    Sollanek, Kurt J.
    Hyatt, Hayden
    Powers, Scott K.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2021, 14 (02): : 481 - 486
  • [48] Effect of long-term angiotensin II type I receptor antagonism on peripheral and coronary vasomotion
    Preumont, N
    Unger, P
    Goldman, S
    Berkenboom, G
    CARDIOVASCULAR DRUGS AND THERAPY, 2004, 18 (03) : 197 - 202
  • [49] Effect of Long-Term Angiotensin II Type I Receptor Antagonism on Peripheral and Coronary Vasomotion
    Nicolas Preumont
    Philippe Unger
    Serge Goldman
    Guy Berkenboom
    Cardiovascular Drugs and Therapy, 2004, 18 : 197 - 202
  • [50] Angiotensin II type 1-receptor antagonism prevents type IIA secretory phospholipase A2-dependent lipid peroxidation
    Luchtefeld, Maren
    Bandlow, Nele
    Tietge, Uwe J. F.
    Grote, Karsten
    Pfeilschifter, Josef
    Kaszkin, Marietta
    Beck, Sabine
    Drexler, Helmut
    Schieffer, Bernhard
    ATHEROSCLEROSIS, 2007, 194 (01) : 62 - 70
12345